Wendy B. Young's most recent trade in Rapport Therapeutics Inc. was a trade of 10,925 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rapport Therapeutics Inc. | Wendy B. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc. | Wendy B. Young | Director | Purchase of securities on an exchange or from another person at price $ 10.21 per share. | 12 Mar 2025 | 6,000 | 6,000 | - | 10.2 | 61,250 | Common Stock |
| F&G Annuities & Life Inc | Wendy J.B. Young | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.58 per share. | 03 Mar 2025 | 4,602 | 80,407 | - | 42.6 | 195,953 | Common Stock |
| F&G Annuities & Life Inc | Wendy Young J.B. | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.33 per share. | 29 Nov 2024 | 6,986 | 83,964 | - | 48.3 | 337,633 | Common Stock |
| F&G Annuities & Life Inc | Wendy J.B. Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 27,471 | 90,950 | - | 0 | Common Stock | |
| Rapport Therapeutics Inc. | Wendy B. Young | Director | 07 Nov 2024 | 29,756 | 29,756 | - | - | Stock Option (Right to Buy) | ||
| F&G Annuities & Life Inc | Wendy J.B. Young | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.47 per share. | 04 Nov 2024 | 139 | 63,479 | - | 40.5 | 5,625 | Common Stock |
| F&G Annuities & Life Inc | Wendy J.B. Young | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.78 per share. | 01 Mar 2024 | 6,337 | 63,618 | - | 37.8 | 239,412 | Common Stock |
| F&G Annuities & Life Inc | Wendy Young J.B. | CFO | Other type of transaction at price $ 25.23 per share. | 31 Dec 2023 | 1,105 | 69,929 | - | 25.2 | 27,882 | Common Stock |
| F&G Annuities & Life Inc | Wendy Young J.B. | CFO | 31 Dec 2023 | 301 | 69,929 | - | 21.3 | 6,423 | Common Stock | |
| F&G Annuities & Life Inc | Wendy J.B. Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 28,319 | 69,221 | - | 0 | Common Stock | |
| F&G Annuities & Life Inc | Wendy J.B. Young | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.84 per share. | 03 Nov 2023 | 152 | 40,902 | - | 32.8 | 4,992 | Common Stock |
| F&G Annuities & Life Inc | J.B. Wendy Young | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.53 per share. | 06 Aug 2023 | 96 | 40,958 | - | 27.5 | 2,643 | Common Stock |
| F&G Annuities & Life Inc | Wendy J.B. Young | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.37 per share. | 28 Feb 2023 | 120 | 41,054 | - | 20.4 | 2,444 | Common Stock |
| F&G Annuities & Life Inc | Wendy J.B. Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 38,991 | 41,174 | - | 0 | Common Stock | |
| F&G Annuities & Life Inc | Wendy J.B. Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 1,335 | 2,183 | - | - | Common Stock |